PPLPHARMA
Piramal Pharma Limited
168.6
-3.10 (-1.81%)
L: 167.55
H: 171.85
Technical Analysis - PPLPHARMA
16 Dec 2025 03:34 PM IST
Lot Size
2500
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 169.11 | 170.39 | 171.18 | 172.45 | 173.73 | 174.52 | 175.79 |
| Bollinger band (1,2) | - | 177.77 | 180.87 | 180.87 | 180.87 | 183.97 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 24.52 |
| Stoch Rsi(14) | 0.22 |
| MACD(12,26) | -6.13 |
| Williams %R | -95.48 |
| ROC | -10.02 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 174.02 | 174.24 |
| MA 20 | 180.87 | 179.86 |
| MA 50 | 190.86 | 187.53 |
| MA 100 | 193.45 | 193.18 |
| MA 200 | 201.14 | 198.34 |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 169.11 | 170.39 | 171.18 | 172.45 | 173.73 | 174.52 | 175.79 |
| Bollinger band (1,2) | - | 177.77 | 180.87 | 180.87 | 180.87 | 183.97 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 28.89 |
| Stoch Rsi(14) | 0.11 |
| MACD(12,26) | -6.35 |
| Williams %R | -95.48 |
| ROC | -10.02 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 174.02 | 174.24 |
| MA 20 | 180.87 | 179.89 |
| MA 50 | 190.77 | 188.45 |
| MA 100 | 204.48 | 187.41 |
| MA 200 | NaN | NaN |
Pivot Points
| Name | S3 | S2 | S1 | Pivot Points | R1 | R2 | R3 |
|---|---|---|---|---|---|---|---|
| Fibonacci | 157.21 | 164.70 | 169.33 | 176.83 | 184.32 | 188.95 | 196.45 |
| Bollinger band (1,2) | - | 177.77 | 180.87 | 180.87 | 180.87 | 183.97 | - |
Technical Indicator
| Name | Value |
|---|---|
| Adx(14) | 0.00 |
| Rsi(14) | 34.68 |
| Stoch Rsi(14) | 0.00 |
| MACD(12,26) | -5.06 |
| Williams %R | -97.48 |
| ROC | -10.02 |
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA 9 | 174.02 | 174.24 |
| MA 20 | 180.87 | 179.59 |
| MA 50 | 193.29 | 180.16 |
| MA 100 | NaN | NaN |
| MA 200 | NaN | NaN |































































































































































































































